US IPO Week Ahead: A pivotal week with 8 IPOs

Eight deals are on the calenda.....»»

Biotech stocks reversed course in the week ended April 16, with the sector re.....»»

Biopharma stocks advanced in the week ended Feb. 5, driven higher by a slew of catalysts. Large-cap pharma earnings, vaccine updates, M&A activity, IPO news flow and follow-on offerings all served to lift stocks higher. read more.....»»

Biopharma stocks advanced in the week ended Feb. 5, driven higher by a slew of catalysts. Large-cap pharma earnings, vac.....»»

Biotech stocks advanced for a third straight week, defying the broader market weakness. The space got solid support from positive stock reactions to presentations made at hematology and breast cancer conferences. read more.....»»

Notwithstanding the ESMO conference generating some huge moves in some stocks, last week turned out to be a muted one for biotechs. read more.....»»

Biotech stocks came under selling pressure in the week ended Sept. 27 amid clinical data readouts and a handful of FDA decisions. read more.....»»

Overbought markets "tend to get hit with sell-offs, especially when we're being flooded with shoddy IPOs," Jim Cramer says......»»

Biotech stocks rebounded in last week after declining modestly in the previous week. read more.....»»

U.S. IPO Week Ahead: Summer"s Last Wave With 5 IPOs.....»»

U.S. IPO Week Ahead: A Flurry Of IPOs Expected To Launch July Roadshows.....»»

For bi.....»»

U.S. IPO Week Ahead: A Biotech Wave Drives 7 IPOs While Slack Targets A Direct Listing.....»»

Biotech stocks staged a recovery this week after being in the red in the previous two weeks. read more.....»»

Biotech stocks staged a recovery this week after being in the red in the previous two weeks. AbbVie Inc (NYSE: ABBV)'s psoriasis drug Skyrizi received FDA nod. The week also saw the release of strong quarterly earnings by big European pharma gian.....»»

Biotech stocks are on track to extend their losses, bucking the positive broader market sentiment. The week saw Achaogen Inc (NASDAQ: AKAO) filing for Chapter 11 bankruptcy and negative clinical readouts .....»»

U.S. IPO Week Ahead: No IPOs But These 12 Deals Can Hop Back In After Easter.....»»

Jim Cramer breaks down the week ahead in earnings and stock trading......»»

Jim Cramer breaks down the week ahead in earnuings and stock trading......»»

Biotech stocks witnessed a slowdown in momentum last week, which was a relatively slow one in terms of news flow. Amgen, Inc. read more.....»»